Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis

Acta Oncologica

Volumn 48, Issue 4, 2009, Pages 578-583

  Rusthoven, Kyle E ^a   Hammerman, Susan F ^a   Kavanagh, Brian D ^a   Birtwhistle, Michael J ^a   Stares, Mark ^a   Camidge, D Ross ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; COMPUTER ASSISTED RADIOTHERAPY; DISEASE COURSE; FEMALE; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; MEDICAL RECORD; MIDDLE AGED; RADIATION DOSE; RADIOSURGERY; RETROSPECTIVE STUDY;

ANTINEOPLASTIC AGENT;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MEDICAL RECORDS; MIDDLE AGED; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 65549125983     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802662722     Document Type: Article

References (24)

1. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;/346:/92-8. (Pubitemid 34438899)
2. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;/355:/2542-50. (Pubitemid 44917502)
3. Herbst RS, Prager D, Hermann R, Fehrenbacher L, Johnson BE, Sandler A, et al. TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2005;/23:/5892-9.
4. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh BD. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2008 (in press).
5. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Mature results of a multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2008 (in press)
6. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Mature results of a multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2008 (in press).
7. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007;/7:/151-60.
8. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;/15:/938-46.
9. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;/ 353:/123-32.
10. Thatcher N, Chang A, Parikh P, Rodrigues Pereira J, Ciuleanu T, von Pawel J, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005;/366:/1527-37.
11. Lilenbaum R, Axelrod R, Thomas S, Dowlati A, Seigel L, Albert D, et al. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced nonsmall- cell lung cancer and a performance status of 2. J Clin Oncol 2008;/26:/863-9.
12. Fukuoka M, Yano S, Giaccone G, Tamura J, Nakagawa K, Douillard JY, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol 2003;/21:/2237-46.
13. Giaccone G, Herbst RS, Manegold C, Scagliotti G, Rosell R, Miller M, et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial INTACT 1. J Clin Oncol 2004;/22:/777-84. (Pubitemid 41103588)
14. Herbst RS, Giaccone G, Schiller JH, Natale RB, Miller V, Manegold C, et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT 2. J Clin Oncol 2004;/22:/785-94. (Pubitemid 41103589)
15. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Vereij J, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;/92:/205-16. (Pubitemid 30099779)
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;/53:/457-81.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;/50:/163-70.
18. Ang KK, Peters LJ, Weber RS, Morrison WH, Frankenthaler RA, Garden AS, et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994;/30:/795-8.
19. Strom EA, Rossi MI. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: Toxicity and local control. Ann Surg Oncol 1995;/2:/445-9.
20. Chang JY, Balter PA, Dong L, Yang Q, Liao Z, JeterM, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;/72:/967-71.
21. Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008;/112:/650-8.
22. Patchell RA, Tibbs PA, Walsh JW, Depsey RJ, Maruyama Y, Kryscio RJ, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;/322:/494-500.
23. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 2004;/363:/1665-72.
24. Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996;/78:/1470-6.